| Rising Phoenix Solutions Wyoming Llc | |
|
2321 Dunn Ave Cheyenne WY 82001-3214 | |
| (307) 314-2319 | |
| Not Available |
| Full Name | Rising Phoenix Solutions Wyoming Llc |
|---|---|
| Speciality | Clinic/Center |
| Location | 2321 Dunn Ave, Cheyenne, Wyoming |
| Authorized Official Name and Position | Kirbie Brown (OWNER) |
| Authorized Official Contact | 3073142319 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Rising Phoenix Solutions Wyoming Llc 1623 Central Ave Ste 202 Cheyenne WY 82001-4531 Ph: () - | Rising Phoenix Solutions Wyoming Llc 2321 Dunn Ave Cheyenne WY 82001-3214 Ph: (307) 314-2319 |
| NPI Number | 1376147876 |
|---|---|
| Provider Enumeration Date | 11/24/2020 |
| Last Update Date | 11/29/2022 |
| Certification Date | 11/29/2022 |
| Medicare PECOS PAC ID | 9335582766 |
|---|---|
| Medicare Enrollment ID | O20240213001199 |
News Archive
A first-of-its kind study led by Xiao-Cheng Wu, MD, MPH, Associate Professor of Public Health at LSU Health Sciences Center New Orleans, reports that a significant number of women are not receiving guideline-recommended treatment for breast cancer and what factors contribute.
Eisai Inc. announced today that the U.S. Food and Drug Administration has granted orphan drug designation to its investigational compound (E7777) for cutaneous t-cell lymphoma. E7777 is designed to have an improved purity profile and manufacturing process.
BioMimetic Therapeutics, Inc. today reported its corporate highlights and financial results as of and for the three and nine months ended September 30, 2012. For the three months ended September 30, 2012, the Company reported a net loss of $4.6 million, or $0.16 per diluted share, compared to a net loss of $7.1 million, or $0.25 per diluted share, for the same period in 2011.
For young people who clearly seem to be developing early signs of schizophrenia, treatment with the antipsychotic drug olanzapine appears to lower or delay the rate of conversion to full-blown psychosis, according to an article by a Yale School of Medicine researcher in the May issue of The American Journal of Psychiatry.
› Verified 1 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1376147876 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | (* (Not Available)) | Secondary |
| 261QM1300X | Clinic/center - Multi-specialty | (* (Not Available)) | Primary |
| Provider Name | Kirbie L Brown |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1609410547 PECOS PAC ID: 6507218567 Enrollment ID: I20240213001291 |
News Archive
A first-of-its kind study led by Xiao-Cheng Wu, MD, MPH, Associate Professor of Public Health at LSU Health Sciences Center New Orleans, reports that a significant number of women are not receiving guideline-recommended treatment for breast cancer and what factors contribute.
Eisai Inc. announced today that the U.S. Food and Drug Administration has granted orphan drug designation to its investigational compound (E7777) for cutaneous t-cell lymphoma. E7777 is designed to have an improved purity profile and manufacturing process.
BioMimetic Therapeutics, Inc. today reported its corporate highlights and financial results as of and for the three and nine months ended September 30, 2012. For the three months ended September 30, 2012, the Company reported a net loss of $4.6 million, or $0.16 per diluted share, compared to a net loss of $7.1 million, or $0.25 per diluted share, for the same period in 2011.
For young people who clearly seem to be developing early signs of schizophrenia, treatment with the antipsychotic drug olanzapine appears to lower or delay the rate of conversion to full-blown psychosis, according to an article by a Yale School of Medicine researcher in the May issue of The American Journal of Psychiatry.
› Verified 1 days ago
News Archive
A first-of-its kind study led by Xiao-Cheng Wu, MD, MPH, Associate Professor of Public Health at LSU Health Sciences Center New Orleans, reports that a significant number of women are not receiving guideline-recommended treatment for breast cancer and what factors contribute.
Eisai Inc. announced today that the U.S. Food and Drug Administration has granted orphan drug designation to its investigational compound (E7777) for cutaneous t-cell lymphoma. E7777 is designed to have an improved purity profile and manufacturing process.
BioMimetic Therapeutics, Inc. today reported its corporate highlights and financial results as of and for the three and nine months ended September 30, 2012. For the three months ended September 30, 2012, the Company reported a net loss of $4.6 million, or $0.16 per diluted share, compared to a net loss of $7.1 million, or $0.25 per diluted share, for the same period in 2011.
For young people who clearly seem to be developing early signs of schizophrenia, treatment with the antipsychotic drug olanzapine appears to lower or delay the rate of conversion to full-blown psychosis, according to an article by a Yale School of Medicine researcher in the May issue of The American Journal of Psychiatry.
› Verified 1 days ago
Mindfully Reconnect Llc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 1001 W 31st St, Cheyenne, WY 82001 Phone: 307-634-6883 Fax: 307-634-9462 | |
Rescare Wyoming, Inc. Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 6215 Clear Creek Pkwy, Cheyenne, WY 82007 Phone: 307-432-9824 | |
Kw Therapy, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1910 Pioneer Ave, Cheyenne, WY 82001 Phone: 970-315-2375 Fax: 844-965-9818 | |
2.0 Counseling Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 2321 Dunn Ave, Cheyenne, WY 82001 Phone: 307-316-2757 Fax: 307-316-8811 | |
Gloria D Rutt Psyd Pc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 2305 Coulter Drive, Cheyenne, WY 82009 Phone: 307-286-4106 Fax: 307-632-6588 | |
Speak Life Llc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 1816 E 17th St, Cheyenne, WY 82001 Phone: 307-426-4204 | |
Cheyenne Child And Family Counseling Center, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 721 E Lincolnway, Cheyenne, WY 82001 Phone: 307-631-9213 |